XN
XiltriX North America, LLC
SEC filingBiotechnology · San Diego, CA
Amount raised$3Msold at filing
Total offering$3M
Investors in the raise20count reported to the SEC
FiledAug 26, 2026first sale Aug 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Erik van StekDirector
Doron LurieDirector
Moises EilembergExecutive Officer, Director
Michael O'ConnellDirector
Hendrik HanselaarDirector
Nathaniel PaigeDirector
Executive officers, directors and promoters as listed on the Form D.